VCAM-1 complements CA-125 in detecting recurrent ovarian cancer

BACKGROUND: Close to three-quarters of ovarian cancer cases are frequently diagnosed at an advanced stage, with more than 70% of them failing to respond to primary therapy and relapsing within 5 years. There is an urgent need to identify strategies for early detection of ovarian cancer recurrence, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jin, Sokoll, Lori J., Zhang, Zhen, Chan, Daniel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291808/
https://www.ncbi.nlm.nih.gov/pubmed/37357306
http://dx.doi.org/10.1186/s12014-023-09414-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291808/
https://www.ncbi.nlm.nih.gov/pubmed/37357306
http://dx.doi.org/10.1186/s12014-023-09414-z

Ejemplares similares